Selective drug taking during combination antiretroviral therapy in an unselected clinic population

Article Abstract:

The frequency, magnitude, associated factors and outcomes of selective drug taking during combination antiretroviral therapy are evaluated. The results indicate that the factors most closely associated with selective drug taking are the presence of an adverse drug event and clinical outcomes appear worse in these patients.

Drugs, Drug therapy, Combination, Combination drug therapy, Adverse drug reactions

---

Efficacy and immunologic responses to Influenza vaccine in HIV-1-infected patients

Article Abstract:

The clinical efficacy and immunologic responses to the influenza vaccine, which is recommended for HIV-1-infected patients, is investigated. It is, then, correlated with the immune response to the vaccine as determined by increased antibody titer and/or hemagglutinin (HA)-specific CD4 T cells.

HIV patients, AIDS vaccines, Immunological research, Immunologic research

---

Modified Dynabeads method for enumerating CD4+ T-Lymphocyte count for widespread use in resource-limited situations

Article Abstract:

The Dynabeads method showed the potential for enumerating CD4+ T lymphocytes in HIV-1-infected individuals. This method is simple, economic, and accurate enough to monitor antiretroviral therapy in resource-limited situations.

HIV infection, Drug therapy, HIV infections, Lymphocytes

Similar abstracts:

• Abstracts: Pertussis-not just for kids. Antiretroviral therapy in a thousand patients with AIDS in Haiti. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children
• Abstracts: Erectile dysfunction following radical prostatectomy. Obesity and erectile dysfunction. A 66-year-old man with sexual dysfunction
• Abstracts: Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings
• Abstracts: The role of nucleoside and nucleotide reverse transcriptase inhibitors backbones in antiretroviral therapy. Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors
• Abstracts: The choice application and review of topical treatments for skin conditions. The assessment of dark skin and dermatological disorders

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.